Company reports all-time-high monthly cartridge sales for July with 60% year-on-year growthNEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its highest-ever monthly cartridge sales for July 2025, with a record 519 boxes shipped, representing over 12,500 cartridges and a 60% increase year-on-year. Cartridges, a higher-margin consumable ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number 001-39825 Intelligent Bio Solutions Inc. (Exact name of Registrant as specified in its Charter) (State or other jurisdiction of i ...

Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue growth of 16%, supported by increased demand for drug testing cartridges NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financi ...

NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing and screening solutions, today announced that its management team will participate in the Sidoti Micro-Cap Virtual Conference being held on August 20-21, 2025. Presentation DetailsDate: Thursday, August 21, 2025Time: 9:15 a.m. Eastern TimeRegistration/Webcast Link: https://sidoti.zoom.us/webinar/register/WN_ieBPB ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 7, 2025 Delaware 001-39825 82-1512711 (IRS employer identification no.) 135 West, 41 Street, 5th Floor New York, NY 10036 INTELLIGENT BIO SOLUTIONS INC. (Exact name of registrant as specified in its charter) (State of Incorporation) (Commission File Number) (Address of principal executiv ...

Proceeds to Fund Completion of the Company’s 510k Filing with the U.S. FDA for its Fingerprint Drug Screening SystemNEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced an agreement between the Company and several current warrant holders to exercise (or prepay the exercise price) certain existing warrants to purchase up to 2,023,228 share ...

Data confirms Company's ability to detect trace sweat volumes at ultra-micro level System demonstrates resilience across diverse conditions NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful collection of new data that further reinforces the security and performance of its Intelligent Fingerprinting Drug Screening System, ...

Company Overview - Intelligent Bio Solutions Inc. (INBS) is a medical technology company focused on delivering intelligent, rapid, non-invasive testing solutions [6] - The company aims to revolutionize portable testing through its Intelligent Fingerprinting Drug Screening System, which analyzes fingerprint sweat for drug use [6] Partnership and Product Expansion - INBS announced a global distribution agreement with SMARTOX® to introduce the SmarTest Patch drug detection product to international markets outside the U.S. and Canada [1][2] - The SmarTest Patch enhances INBS's product portfolio by providing continuous sweat-based drug detection over an extended period, targeting sectors such as justice and rehabilitation [2][3] Market Potential - The global drug testing market is projected to grow significantly, reaching approximately $18.6 billion by 2030, presenting new opportunities for INBS [2] - The partnership with SMARTOX supports INBS's international growth strategy and introduces an additional revenue stream aligned with its broader expansion goals [2] Regulatory Strategy - INBS is prioritizing securing FDA clearance for its fingerprint sweat-based drug testing technology for use beyond forensic settings as part of its U.S. expansion strategy [4] - The company is actively engaging with regulatory consultants and stakeholders to bring its innovative solution to market in the U.S. [4] Current Operations - INBS currently serves over 450 active accounts in 24 countries, providing non-invasive drug testing solutions across health, justice, and workplace sectors [3]

Core Insights - Intelligent Bio Solutions Inc. has introduced the SmarTest® Patch, a non-invasive drug testing solution that detects substances through sweat over a 7 to 10-day period [1][2] - The SmarTest Patch complements the existing Intelligent Fingerprinting Drug Testing Solution, enhancing the company's product portfolio in non-invasive testing technologies [1][2] Product Features - The SmarTest Patch is discreet, water-resistant, and tamper-evident, designed to continuously collect sweat for drug detection [2] - It can detect a wide range of substances, including cocaine, opiates, methamphetamines, marijuana, and fentanyl [2] - The differing detection windows of the SmarTest Patch and the Intelligent Fingerprinting Drug Screening System allow the company to meet varied customer requirements [2][3] Market Opportunities - The introduction of the SmarTest Patch opens new opportunities in markets requiring longer detection windows, particularly in justice and rehabilitation settings [3] - The product enhances the company's commercial edge by providing customers with more adaptable tools for both short and long-term detection needs [3] Company Background - Intelligent Bio Solutions Inc. focuses on delivering rapid, non-invasive testing solutions and aims to revolutionize portable testing through fingerprint sweat analysis [5] - The company targets various customer segments outside the U.S., including construction, manufacturing, transport, and drug treatment organizations [5] Partner Information - SMARTOX, the developer of the SmarTest Patch, is a U.S.-based provider of drug and alcohol testing products and services, committed to advanced technology and exceptional results [4] - SMARTOX is actively expanding its presence in forensic testing markets through investments and pilot programs [4]

Core Insights - Intelligent Bio Solutions Inc. (INBS) is set to present its Pharmacokinetic (PK) study data at the ADLM 2025 Clinical Lab Expo, showcasing the effectiveness of its Intelligent Fingerprinting Drug Screening System for non-invasive drug testing [2][4]. Group 1: Study Findings - The PK study demonstrated that fingerprint sweat can accurately reflect the rate and extent of codeine found in blood and saliva, indicating its reliability for drug detection [3]. - Statistical comparisons at a 95% confidence level confirmed that fingerprint sweat serves as a dependable sample matrix for drug screening [3]. Group 2: Event Participation - Daniel Brown, Head of Clinical Affairs at INBS, will represent the company at the ADLM event, engaging with attendees and presenting the study's methodology and findings [4]. - ADLM 2025 is a significant global exposition for laboratory medicine, featuring over 300 expert speakers and more than 250 educational sessions [5]. Group 3: Company Overview - INBS's Drug Screening System is designed for accurate and efficient testing across various sectors, including construction, transportation, and manufacturing, with over 450 accounts in 24 countries [7]. - The Intelligent Fingerprinting Drug Screening System aims to revolutionize portable testing through rapid sample collection and results, making it a valuable tool for safety-critical industries [8].